Articles tagged with: Lung

RECRUITING: ATOMIC-meso, a Global Randomised Trial of Triplet Drug Therapy for Malignant Mesothelioma

Posted in General News Published by Reza Roozitalab 19 October 2017

ADI-PEG20 continues to show promise

RECRUITING: ATOMIC-meso, a Global Randomised Trial of Triplet Drug Therapy for Malignant Mesothelioma

Several ongoing clinical trials, led by Dr Peter Szlosarek at the Barts Cancer Centre, continue to investigate the clinical efficacy of "arginine starvation" using ADI-PEG20...

Encouraging results for a new mesothelioma chemotherapy

Posted in Publications Published by Zoe Leech 12 April 2017

Other hard-to-treat cancers are now being tested

Encouraging results for a new mesothelioma chemotherapy

A new publication from Dr Peter Szlosarek and his team in the Journal of Clinical Oncology marks the next step in the development of a revolutionary treatment for mesothelioma.

This cancer of the lung lining is hard to treat and an increasing problem as more people develop the condition...

New PCRF grants and Industrial CASE studentship awarded

Posted in Grants & Awards Published by Zoe Leech 18 January 2017

New PCRF grants and Industrial CASE studentship awarded

Three of our researchers in the Centres for Tumour Biology and Molecular Oncology have recently won awards allowing them to begin and continue research projects in pancreatic cancer and make headway in finding new treatments...

Tactics to overcome mesothelioma treatment resistance

Posted in Publications Published by Zoe Leech 26 July 2016

Tactics to overcome mesothelioma treatment resistance

Pioneering work in our labs has led to a new "starvation" treatment strategy for mesothelioma, previously almost untreatable due to the difficulty of performing effective surgery and lack of available drugs.

Dr Sarah Martin has published new work on how mesothelioma could get around the attack with a view to preventing resistance and killing the cancer more efficiently...

A new strategy to improve cancer treatment: Vascular Promotion Therapy

Posted in BCI Spotlight Articles, Publications Published by Zoe Leech 06 February 2015

A new strategy to improve cancer treatment: Vascular Promotion Therapy

A paper published in Cancer Cell recently from Professor Kairbaan Hodivala-Dilke‚Äôs laboratory could mark the beginning of a new strategy in cancer treatment.

The new tactics, tested in models of solid lung and pancreatic tumours, achieved four major goals: improved drug delivery to tumour cells; reduced tumour growth; decreased tumour spread (metastasis); and extended survival...

"Starving" mesothelioma: a new treatment approach

Posted in In the Press, Publications Published by Marianne Baker 09 December 2013

Starving cancer cells of a key amino acid slows down their ability to grow and multiply, according to new research co-ordinated by Dr Peter Szlosarek here at BCI. Dr Szlosarek announced the findings on October 28th at the World Conference on Lung Cancer in Sydney, Australia, and they are now published in the journal Cancer Research. The Daily Express has covered this news.

The team have been working on one of Britain's deadliest rare cancers, mesothelioma...

Stoptober: lung cancer research at BCI

Posted in General News Published by Marianne Baker 18 October 2013

Stoptober: lung cancer research at BCI

Lung cancer is the most common cancer worldwide, with over 1.6 million new cases diagnosed each year.

There has been extensive research around the treatment and management of advanced stage lung cancer, which has led to improved patient survival. However, much less is known about the early events that occur in the cells of the lung that lead to the development of lung cancer...

Lung Cancer Alliance launched

Posted in General News Published by Marianne Baker 02 May 2013

Lung Cancer Alliance launched

London Lung Cancer Alliance launched to transform patient care

Leading research institutions and hospitals across London, including Barts Cancer Institute, have united to transform lung cancer care by inviting patients from a population of six million into a pioneering new programme of clinical trials...

This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.